SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity of $250.11M in Q1 FY2026

Q1 FY2026 total equity was $250.11M.

Context

  • Total equity amounted to 96.8% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$250.11M+353.1% QoQ
Last fiscal yearDec 2025
-$98.84M— YoY
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
(98.84M) USD
Year-over-year change
—

Total Equity vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Total equity amounts to 96.8% of total assets for SGP, versus a peer median of 78.1%.
SGP Competitors
Total Equity for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$21.73B USD-1.5%+3.8%69.3%
BLCOBausch + Lomb CorporationJun 2026$6.44B USD-1.0%-2.8%46.5%
GKOSGlaukos CorporationJun 2026$682.49M USD-10.8%+7.4%74.1%
OCULOcular Therapeutix, Inc.Mar 2026$581.57M USD+118.7%+164.5%79.4%
STAASTAAR Surgical CompanyApr 2026$352.37M USD+0.7%+0.8%78.1%
RXSTRxSight, Inc.Mar 2026$267.3M USD-4.3%+45.3%87.9%
SGPSpyGlass Pharma, Inc. Common StockMar 2026$250.11M USD——96.8%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$230.47M USD-22.8%+47.0%80.0%
OCSOculis Holding AGMar 2026CHF 196.06M CHF+20.6%—80.6%
SGHTSight Sciences, Inc.Mar 2026$53.9M USD-30.6%-26.4%49.1%
Peer median (excluding SGP) —-1.5%+5.6%78.1%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.